There are no plans for Northeastern Illinois University to provide the COVID-19 vaccine at this time. Vaccination distribution and administration are currently being coordinated by the Illinois Department of Public Health (IDPH) and Chicago Department of Public Health (CDPH). Here we provide additional information about COVID-19 vaccinations.
Where do I get vaccinated?
IDPH is the overall authority responsible for distribution in the State of Illinois. We are currently in Phase 1B of the plan. The vaccination plan is outlined online. View the vaccination locations for the state, Cook County and Chicago.
The City of Chicago, through CDPH, has constructed mass vaccination sites along with designated points of dispensing to vaccinate the public according to the phases outlined by IDPH. The latest updates from the city can be viewed online.
President Joe Biden has outlined federal priorities for the COVID-19 vaccination effort.
Illinois is using four phases to determine who can receive the vaccine:
- Illinois and the City of Chicago are currently entering phase 1B of the state vaccination plan.
- State of Illinois vaccination progress.
Vaccination rollout is a rapidly changing landscape. Monitor reliable news sources and public health authorities to stay up to date.
COVID-19 vaccinations are being produced using new and existing vaccine technologies:
- mRNA vaccines are a new type of vaccine to protect against infectious diseases. mRNA vaccines teach our cells how to make a protein—or even just a piece of a protein—that triggers an immune response inside our bodies. Moderna and Pfizer-BioNTech are the two vaccines currently approved by the U.S. Food and Drug Administration (FDA) to be used to vaccinate against COVID-19. Be aware:
- This type of vaccination cannot give someone COVID-19 because mRNA vaccines do not use the live virus that causes COVID-19.
- This vaccination does not affect or interact with our DNA in any way. mRNA never enters the nucleus of the cell, which is where our DNA (genetic material) is kept.
- Viral Vector vaccine uses a safe virus to deliver specific sub-parts—called proteins—of the COVID-19 virus, so that it can trigger an immune response without causing disease. The Astra Zeneca and Johnson & Johnson vaccines use this technology and are in the final stages of FDA approval. Be aware:
- This vaccine cannot give someone COVID-19 or other infections. Viral vectors cannot cause infection with COVID-19 or with the virus used as the vaccine vector.
- This vaccine does not affect or interact with our DNA in any way. The genetic material delivered by the viral vector does not become part of a person’s DNA.
Understanding COVID vaccines
- WHO - COVID vaccines explained
- Vaccine Alliance - COVID vaccines
- A comprehensive list of vaccines and their current development stage is available at the New York Times vaccine tracker.
The FDA has granted Emergency Use Authorizations for two COVID-19 vaccines that have been shown to be safe and effective as determined by data from the manufacturers and findings from large clinical trials. These data demonstrate that the known and potential benefits of this vaccine outweigh the known and potential harms of becoming infected with COVID-19.
As with all vaccines, there are side effects associated with administration of the COVID-19 vaccines. The benefits associated with vaccination have been found to outweigh the associated risks.
Public health recommendations for vaccinated persons
Given the currently limited information on how much the mRNA COVID-19 vaccines may reduce transmission in the general population and how long protection lasts, vaccinated persons should continue to follow all current guidance to protect themselves and others. This includes wearing a mask, staying at least 6 feet away from others, avoiding crowds, washing hands often, following CDC travel guidance, following quarantine guidance after an exposure to someone with COVID-19, and following any applicable workplace or school guidance, including guidance related to personal protective equipment use or SARS-CoV-2 testing.